3,4-dihydroxyphenylglycol has been researched along with entacapone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordin, A; Heinävaara, S; Illi, A; Koulu, M; Scheinin, M; Sundberg, S | 1 |
| Illi, A; Koulu, M; Ojala-Karlsson, P; Scheinin, M | 1 |
| Akiyama, T; Fujii, T; Mori, H; Sano, S; Yamazaki, T | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylglycol and entacapone
| Article | Year |
|---|---|
COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Chromatography, High Pressure Liquid; Electrocardiography; Exercise Test; Hemodynamics; Humans; Male; Methoxyhydroxyphenylglycol; Nitriles; Reference Values | 1994 |
Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
Topics: Antiparkinson Agents; Benzamides; Biomarkers; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pentanones; Selegiline | 1998 |
Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.
Topics: Animals; Blood Pressure; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Heart Rate; Male; Methoxyhydroxyphenylglycol; Microdialysis; Models, Animal; Myocardial Ischemia; Myocardium; Nitriles; Norepinephrine; Normetanephrine; Rabbits | 2004 |